FDA approves UZEDY ® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to ...
Contributed by Jeffery W. Kelly; received November 13, 2024; accepted May 21, 2025; reviewed by Ana Maria Cuervo and Kerry Kornfeld ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback